参考文献/References:
[1] Vaarala O,Yki-J?覿rvinen H．Diabetes：should we treat infection or inflammation to prevent T2DM[J]?.Nat Rev Endocrinol, 2012,8（6）：323-325.
[2] Fernández-Real JM,Pickup JC．Innate immunity,insulin resis-tance and type 2 diabetes[J]．Diabetologia,2012,55（2）：273-278．
[3] Kawai T,Akira S．The roles of TLRs,RLRs and NLRs in pathogen recognition[J]．Int Immunol,2009,21（4）：317-337．
[4] Schertzer JD,Tamrakar AK,Magalh?觔es JG,et al．NOD1 activa-tors link innate immunity to insulin resistance[J]．Diabetes, 2011,60（9）：2206-2215．
[5] Mori MA,Bezy O,Kahn CR．Metabolic syndrome：is Nlrp3 inflammasome a trigger or a target of insulin resistance [J]?.Circ Res,2011,108（10）：1160-1162．
[6] Yin Y,Pastrana JL,Li X,et al．Inflammasomes：sensors of metabolic stresses for vascular inflammation[J]．Front Biosci （Landmark Ed）,2013,18：638-649．
[7] Schroder K,Zhou R,Tschopp J．The NLRP3 inflammasome：a sensor for metabolic danger [J]?.Science,2010,327（5963）：296-300．
[8] Lee MS．Role of innate immunity in diabetes and metabolism： recent progress in the study of inflammasomes[J]．Immune Netw, 2011,11（2）：95-99．
[9] Grant RW,Dixit VD．Mechanisms of disease：inflammasome activation and the development of type 2 diabetes[J]．Front Immunol,2013,4:50.
[1０] Lee HM,Kim JJ,Kim HJ,et al．Upregulated NLRP3 inflamma-some activation in patients with type 2 diabetes[J].Diabetes, 2013,62（1）：194-204．
[11] Dagenais M,Skeldon A,Saleh M．The inflammasome：in memory of Dr．Jurg Tschopp[J]．Cell Death Differ,2012,19（1）：5-12．
[12] Koenen TB,Stienstra R,van Tits LJ,et al．Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue[J]．Diabetes,2011,60（2）：517-524．
[13] Zhou R,Tardivel A,Thorens B,et al．Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J]．Nat Immunol,2010,11（2）：136-140．
[14] Wada J,Makino H．Inflammation and the pathogenesis of diabetic nephropthy[J]．Clin Sci（Lond）,2013,124（3）：139-152．
[15] Chen K,Zhang J,Zhang W,et al．ATP-P2X4 signaling mediates NLRP3 inflammasome activation：a novel pathway of diabetic nephropathy[J]．Int J Biochem Cell Biol,2013,45（5）：932-943．
[16] Benetti E,Chiazza F,Patel NS．et al．The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders[J]．Mediators Inflamm,2013,2013：678627．
[17] Wang C,Pan Y,Zhang QY,et al．Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation[J]．PLoS One,2012,7（6）：e38285．
[18] Devi TS,Lee I,Hüttemann M,et al．TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia：implications for diabetic retinopathy[J]．Exp Diabetes Res,2012,2012：438238.
[19] Sbai O,Devi TS,Melone MA,et al．RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration,fibronectin expression and cytokine secretion[J]．J Cell Sci,2010,123（Pt 24）：4332-4339.
[2０] McGettrick AF,O'Neill LA．How metabolism generates signals during innate immunity and inflammation[J]．J Biol Chem,2013, 288（32）：22893-22898．
[21] Lee MS．Role of innate immunity in diabetes and metabolism： recent progress in the study of inflammasomes[J]．Immune Netw,2011,11（2）：95-99.
[22] Duewell P,Kono H,Rayner KJ,et al．NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J]．Nature,2010,464（7293）：1357-1361．
[23] De Nardo D,Latz E．NLRP3 inflammasomes link inflammation and metabolic disease[J]． Trends Immunol,2011,32（8）： 373-379．
相似文献/References:
[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(01):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
[11]邵金双,邸阜生.网膜素抗炎作用及与代谢相关疾病的关系[J].国际内分泌代谢杂志,2014,(01):29.[doi:10.3760/cma.j.issn.1673-4157.2014.01.008]
Shao Jinshuang*,Di Fusheng ..Anti-inflammatory effect of omentin and its relationship with metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(01):29.[doi:10.3760/cma.j.issn.1673-4157.2014.01.008]